Drs Gayatri Acharya, Michael Ackerman, and Peter Noseworthy discuss the importance of investigating sudden deaths in light of new research showing that many presumed sudden cardiac deaths are not cardiac in origin.

Dr Eric Topol speaks with science journalist Carl Zimmer about where he gets his ideas, what his genome looks like, and how he got a tapeworm named after him.

Dr Lundberg shares a possible aid for metabolizing alcohol.

Dr Califf talks about his new role at Verily and how data mining and data sharing could reduce disparities in care and improve patient outcomes.

Eric Topol gets the backstory from Beth Stevens on the amazing discoveries being made about the role of the immune system in neurologic diseases.

Dr Markman encourages review of recently reported possible effect of ovarian cancer antineoplastic agents in breast cancer patients with rare BRCA mutational signatures.

Reviewing recent research, Dr Jeffrey Weber concludes that an amalgam of host- and tumor-related markers will be the best indication of which patients should receive checkpoint inhibitors.

Dr Eric Topol interviews CRISPR scientist Feng Zhang about his journey from China to the gene editing labs of America.

Without a gold standard for myriad parameters, precision oncology is imprecise, at best, argues Dr Lundberg.

The just-released Testosterone Trials provide more information on screening for or treating low T. Should family physicians intervene in older men?